Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir
Status:
Completed
Trial end date:
2021-10-09
Target enrollment:
Participant gender:
Summary
This is a drug-drug interaction study to assess the effects of a single dose of
PF-07321332/ritonavir after multiple dose administrations of carbamazepine. Pharmacokinetic
(PK) will be evaluated for PF-07321332 and ritonavir. Carbamazepine is being utilized as a
cytochrome P450 3A4 (CYP3A4) inducer.